Psyence Biomedical Ltd. (PBM) NASDAQ

5.21

-0.445(-7.88%)

Updated at July 03 04:00PM

Currency In USD

Valuation

Market Cap3.9B
Enterprise Value3.91B
P/E Ratio-0.08
PEG Ratio-0
Price/Sales Ratio0
Price/Book Ratio-1.57
Enterprise/Revenue0
Enterprise/EBITDA-9.69

Fiscal Year

Fiscal YearMarch 31, 2024
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-10.93
Return On Equity38.89

Income Statement

Revenue0
Revenue/Share0
Gross Profit-240
EBITDA-2.75M
Net Income-51.16M
Diluted EPS-7.85

Balance Sheet

Total Cash1.93M
Total Cash/Share6.98
Total Debt2.5M
Total Debt/Equity-1.99
Current Ratio0.64
Book Value Per Share-4.54

Price History

52-Week Change-96.71
52-Week High702
52-Week Low2.94
Moving Average 50 Days4.64
Moving Average 200 Days21.21

Statistics

Average Volume99,072
Shares Outstanding583,263
% Held by Institutions103.98

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateMay 05, 2025